Position in SYK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$629
-$3,067 QoQ
Shares Held
2
-80.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,243
of 2,252 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SYK Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Trifecta Capital Advisors, LLC holds $560,026 across 7 Medical Devices names. SYK ranks #5 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
4,350 | $393,501 | |
| 2 | ABT |
Abbott Laboratories
|
1,665 | $151,082 | |
| 3 | BSX |
Boston Scientific Corp
|
304 | $12,974 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
14 | $896 | |
| 5 | SYK |
Stryker Corp
This page
|
2 | $629 | |
| 6 | BRKR |
Bruker Corp
|
9 | $541 | |
| 7 | SNN |
Smith & Nephew PLC
|
14 | $403 |
All Filings in SYK
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $629 | 2 | Shares | Sole | 2026-08-03 | |
| 2025-09-30 | $3,696 | 10 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $3,956 | 10 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,722 | 10 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $3,600 | 10 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $17,701 | 49 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $3,402 | 10 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $3,578 | 10 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,994 | 10 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,732 | 10 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,050 | 10 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,854 | 10 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,444 | 10 | Shares | Sole | 2023-01-18 | |
| No filing history on record for this holder in this stock. | ||||||